- Home
- ARWR vs LNN Comparison
ARWR vs LNN Comparison
Compare ARWR & LNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARWR
- LNN
- Stock Information
- Founded
- ARWR 2003
- LNN 1954
- Country
- ARWR United States
- LNN United States
- Employees
- ARWR N/A
- LNN N/A
- Industry
- ARWR Biotechnology: Pharmaceutical Preparations
- LNN Industrial Machinery/Components
- Sector
- ARWR Health Care
- LNN Industrials
- Exchange
- ARWR Nasdaq
- LNN Nasdaq
- Market Cap
- ARWR 1.8B
- LNN 1.5B
- IPO Year
- ARWR 1993
- LNN 1988
- Fundamental
- Price
- ARWR $13.07
- LNN $133.46
- Analyst Decision
- ARWR Buy
- LNN Hold
- Analyst Count
- ARWR 11
- LNN 1
- Target Price
- ARWR $41.44
- LNN $128.00
- AVG Volume (30 Days)
- ARWR 1.7M
- LNN 75.6K
- Earning Date
- ARWR 05-12-2025
- LNN 06-26-2025
- Dividend Yield
- ARWR N/A
- LNN 1.08%
- EPS Growth
- ARWR N/A
- LNN 12.44
- EPS
- ARWR N/A
- LNN 7.03
- Revenue
- ARWR $2,500,000.00
- LNN $647,542,000.00
- Revenue This Year
- ARWR $4,380.43
- LNN $11.29
- Revenue Next Year
- ARWR $64.24
- LNN $3.37
- P/E Ratio
- ARWR N/A
- LNN $18.96
- Revenue Growth
- ARWR N/A
- LNN 0.46
- 52 Week Low
- ARWR $9.57
- LNN $109.27
- 52 Week High
- ARWR $30.41
- LNN $140.26
- Technical
- Relative Strength Index (RSI)
- ARWR 53.31
- LNN 57.39
- Support Level
- ARWR $12.44
- LNN $130.72
- Resistance Level
- ARWR $14.97
- LNN $136.00
- Average True Range (ATR)
- ARWR 0.71
- LNN 3.34
- MACD
- ARWR 0.16
- LNN 0.68
- Stochastic Oscillator
- ARWR 61.36
- LNN 74.87
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About LNN Lindsay Corporation
Lindsay Corp provides various proprietary water management and road infrastructure products and services. It has operations categorized into two main reporting segments: Irrigation, and Infrastructure. The company generates maximum revenue from the Irrigation segment. Its Irrigation segment includes manufacturing and marketing center pivot, lateral move, and hose reel irrigation systems, as well as various technology solutions such as GPS positioning and guidance, variable rate irrigation, wireless irrigation management, M2M communication technology, and smartphone applications. Geographically, it derives a majority of its revenue from the United States.